Beasley Allen in the News

Articles 341 to 350 of 684 .

Executive points to 2000 study that Supported Vioxx

| December 7, 2005
Two Merck executives involved in the development of the blockbuster drug Vioxx testified there was no clinical evidence it could cause heart attacks and strokes when it was approved for sale five years ago.

Merck Executive Denies pressuring Doctor ver Vioxx

| December 7, 2005
A Merck executive denied today she tried to pressure one of the nation's top cardiologists into not publishing an article in a highly respected medical journal raising concerns that Vioxx could cause heart attacks and strokes.

No verdict set in Vioxx trial, jurors to return Saturday

The Houston Chronicle | December 7, 2005
Jurors deliberated about eight hours today without reaching a verdict on whether Merck & Co.'s Vioxx contributed to the 2001 death of a Florida man who had been taking the once-popular painkiller for about a month.

Merck exec denies pressuring doctor over Vioxx

The Houston Chronicle | December 7, 2005
A Merck executive denied today she tried to pressure one of the nation's top cardiologists into not publishing an article in a highly respected medical journal raising concerns that Vioxx could cause heart attacks and strokes.

Merck Rests its Defense in Federal Vioxx Trial

National Public Radio | December 7, 2005
NPR.org, December 7, 2005 – Merck rested its case Wednesday afternnon in the first deferral Vioxx trial after testimony from a pathologist who said the painkiller played no role in the fatal heart attack of 53-year-old Richard “Dicky” Irvin.

Merck Stresses Concern for Vioxx users Safety

| December 6, 2005
Witnesses for drug manufacturer Merck presented the company and its scientists as careful, methodical and, above all, concerned about the safety of the users of its drugs.

Merck Stresses Concern for Vioxx Users' Safety

National Public Radio | December 6, 2005
NPR.org, December 6, 2005 âe" In the first full day of defense testimony at the federal Vioxx trial in Houston, witnesses for drug manufacturer Merck presented the company and its scientists as careful, methodical and, above all, concerned about the safety of the users of its drugs.

Doctor testifies even low doses of Vioxx dangerous

The Houston Chronicle | December 2, 2005
A doctor who has analyzed the effects of Vioxx on the heart denied today that four studies that he says showed the link in low-dose use were statistically insignificant.

Doctor Testifies that Merck Studies Showed Vioxx Risks

The Wall Street Journal | December 1, 2005
HOUSTON – Many of Merck's own studies in Vioxx produced data indicating that the painkiller increase risks of hear attacks, even if taken over a short period of time, an epidemiologist testified on behalf of plaintiffs in a federal case here.

Third Merck Trial

| November 30, 2005
Merck hid the health risks of Vioxx to protect profit, a lawyer representing the family of a man who died after using the pain reliever for 23 days told jurors yesterday in the first federal trial over the drug.